Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine vs Lidocaine for Postoperative Cognitive Dysfunction in Hip Surgery
NCT07838909Completed
- Sponsor
- Tanta University
- Start
- Mar 2025
- Primary completion
- Mar 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial in Post-operative cognitive dysfunction (POCD) comparing Group Ketamine, Group Lidocaine and Group Placebo (3 arms). Primary endpoint: Incidence of postoperative cognitive dysfunction at 3 days. Started Mar 2025; status: completed.
02
Drugs
ketamineLidocaine Hydrochloride Injection, without epinephrine
03
Conditions
Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT07838909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07838909.